Scilex Holding Company, a Majority-Owned Subsidiary of : vim

Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140...

Related Keywords

United States , California , Turkey , New York , Delaware , San Diego , Palo Alto , Turk , Steven Ross Johnson , Jaisim Shah , Henry Ji , Loeb , Jeffrey Chi , Deyo Weinstein , Mailis Gagnon , Semnur Pharmaceuticals Inc , Vickers Vantage Corp , Nasdaq , Scilex Holding Company , Paul Hastings , Celularity Inc , Vickers Venture Fund Vi Plan Pte Ltd , Pivotal Trialc Le Ar Program , Scilex Pharmaceuticals Inc , Company Or Scilex , Centers For Disease , Drug Administration , Exchange Commission , Vickers Venture Fund Vi Pte Ltd , Sorrento Therapeutics Inc , Vickers Vantage , Combined Company , Sorrento Therapeutics , Vickers Venture Fund , Holding Company , Pte Ltd , Chief Executive Officer , Vice Chairman , Vickers Venture , Disease Control , Executive Chairman , Chief Executive , Current Report , Lumbar Epidural Analgesia , Text View , Securities Act , Private Securities Litigation Reform Act , Nasdaq Capital Market , Media Contact , Nicolette Ten , Senior Account Executive , Semnur Pharmaceuticals , Scilex Holding , All Rights , Pain Symptom Manage , Database Syst Rev , National Institutes , Health Pathways , Ann Intern Med , Drug Overdose Deaths Top , First Time , Nasdaq Srne , Nc ,